AGIOS PHARMACEUTICALS, INC.
Pharmaceutical Preparations | SIC: 2834Phone: 617-649-8600
State Location: MA
State of Inc.: DE
- Nasdaq:AGIO
Form: 8-K
Filing Date: 12 Feb 2026Report Date: 12 Feb 2026
Accepted: 12 Feb 2026 04:32 a.m.
Accession Number: 0001439222-26-000023
File Number: 001-36014
Film Number: 26623268
Items: 2.02,9.01
Documents
Primary Document: 8-K
Accepted: 12 Feb 2026 04:32 a.m.
0001439222-26-000023-index-headers.html
Last Modified: 12 Feb 2026 04:32 a.m.
0001439222-26-000023-index.html
Last Modified: 12 Feb 2026 04:32 a.m.
0001439222-26-000023.txt
Last Modified: 12 Feb 2026 04:32 a.m.
0001439222-26-000023-xbrl.zip
Last Modified: 12 Feb 2026 04:32 a.m.
agio-20260212.xsd
Last Modified: 12 Feb 2026 04:32 a.m.
agio-20260212_htm.xml
Last Modified: 12 Feb 2026 04:32 a.m.
agio-20260212_lab.xml
Last Modified: 12 Feb 2026 04:32 a.m.
agio-20260212_pre.xml
Last Modified: 12 Feb 2026 04:32 a.m.
agio-21226xfyxex991earning.htm
Last Modified: 12 Feb 2026 04:32 a.m.
agios_2021xlogo.jpg
Last Modified: 12 Feb 2026 04:32 a.m.
FilingSummary.xml
Last Modified: 12 Feb 2026 04:32 a.m.
MetaLinks.json
Last Modified: 12 Feb 2026 04:32 a.m.
R1.htm
Last Modified: 12 Feb 2026 04:32 a.m.
report.css
Last Modified: 12 Feb 2026 04:32 a.m.
Show.js
Last Modified: 12 Feb 2026 04:32 a.m.